Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Association of Dopamine Beta-Hydroxylase Polymorphisms with Alzheimer's Disease, Parkinson's Disease and Schizophrenia: Evidence Based on Currently Available Loci.

Tang S, Yao B, Li N, Lin S, Huang Z.

Cell Physiol Biochem. 2018;51(1):411-428. doi: 10.1159/000495238. Epub 2018 Nov 19.

2.

Genetics of Aggression in Alzheimer's Disease (AD).

Lukiw WJ, Rogaev EI.

Front Aging Neurosci. 2017 Apr 10;9:87. doi: 10.3389/fnagi.2017.00087. eCollection 2017.

3.

Polymorphisms in the aldehyde dehydrogenase 2 and dopamine β hydroxylase genes are not associated with Alzheimer's disease.

Komatsu M, Shibata N, Ohnuma T, Kuerban B, Tomson K, Toda A, Tagata Y, Nakada T, Shimazaki H, Arai H.

J Neural Transm (Vienna). 2014 Apr;121(4):427-32. doi: 10.1007/s00702-013-1112-z. Epub 2013 Nov 8.

PMID:
24201835
4.

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.

Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A.

Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24. Review.

PMID:
23707776
5.

Genotype-independent decrease in plasma dopamine beta-hydroxylase activity in Alzheimer's disease.

Mustapic M, Presecki P, Pivac N, Mimica N, Hof PR, Simic G, Folnegovic-Smalc V, Muck-Seler D.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:94-9. doi: 10.1016/j.pnpbp.2013.02.002. Epub 2013 Feb 13.

6.

Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.

Hammerschmidt T, Kummer MP, Terwel D, Martinez A, Gorji A, Pape HC, Rommelfanger KS, Schroeder JP, Stoll M, Schultze J, Weinshenker D, Heneka MT.

Biol Psychiatry. 2013 Mar 1;73(5):454-63. doi: 10.1016/j.biopsych.2012.06.013. Epub 2012 Aug 9.

7.

The vitamin D receptor gene is associated with Alzheimer's disease.

Lehmann DJ, Refsum H, Warden DR, Medway C, Wilcock GK, Smith AD.

Neurosci Lett. 2011 Oct 24;504(2):79-82. doi: 10.1016/j.neulet.2011.08.057. Epub 2011 Sep 3.

PMID:
21911036
8.

Cellular localization of debromohymenialdisine and hymenialdisine in the marine sponge Axinella sp. using a newly developed cell purification protocol.

Song YF, Qu Y, Cao XP, Zhang W.

Mar Biotechnol (NY). 2011 Oct;13(5):868-82. doi: 10.1007/s10126-010-9347-2. Epub 2011 Jan 19.

PMID:
21246234
9.

Differential response of the central noradrenergic nervous system to the loss of locus coeruleus neurons in Parkinson's disease and Alzheimer's disease.

McMillan PJ, White SS, Franklin A, Greenup JL, Leverenz JB, Raskind MA, Szot P.

Brain Res. 2011 Feb 10;1373:240-52. doi: 10.1016/j.brainres.2010.12.015. Epub 2010 Dec 11.

10.

The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project.

Combarros O, Warden DR, Hammond N, Cortina-Borja M, Belbin O, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Barber R, Coto E, Alvarez V, Deloukas P, Gwilliam R, Heun R, Kölsch H, Mateo I, Oulhaj A, Arias-Vásquez A, Schuur M, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Morgan K, Smith AD, Lehmann DJ.

BMC Med Genet. 2010 Nov 11;11:162. doi: 10.1186/1471-2350-11-162.

11.

Impairments in working memory and decision-taking processes in monkeys in a model of Alzheimer's disease.

Dudkin KN, Chueva lV, Makarov FN, Bich TG, Roer AE.

Neurosci Behav Physiol. 2005 Mar;35(3):281-9.

PMID:
15875490
12.

Increased lymphocyte dopamine beta-hydroxylase immunoreactivity in Alzheimer's disease: compensatory response to cholinergic deficit?

Giubilei F, Calderaro C, Antonini G, Sepe-Monti M, Tisei P, Brunetti E, Marchione F, Caronti B, Pontieri FE.

Dement Geriatr Cogn Disord. 2004;18(3-4):338-41. Epub 2004 Aug 6.

PMID:
15305112
13.

Noradrenergic innervation of human pineal gland: abnormalities in aging and Alzheimer's disease.

Jengeleski CA, Powers RE, O'Connor DT, Price DL.

Brain Res. 1989 Mar 6;481(2):378-82.

PMID:
2720390
14.

Dopamine-beta-hydroxylase activities in serum and cerebrospinal fluid of aged and demented patients.

Miyata S, Nagata H, Yamao S, Nakamura S, Kameyama M.

J Neurol Sci. 1984 Mar;63(3):403-9.

PMID:
6726279
15.

Neurotransmitters in dementia.

Nakamura S, Koshimura K, Kato T, Yamao S, Iijima S, Nagata H, Miyata S, Fujiyoshi K, Okamoto K, Suga H, et al.

Clin Ther. 1984;7 Spec No:18-34.

PMID:
6152197
16.

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type.

Iversen LL, Rossor MN, Reynolds GP, Hills R, Roth M, Mountjoy CQ, Foote SL, Morrison JH, Bloom FE.

Neurosci Lett. 1983 Aug 19;39(1):95-100.

PMID:
6633940
17.

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ.

J Neurol Sci. 1981 Aug;51(2):279-87.

PMID:
7276979

Supplemental Content

Loading ...
Support Center